BOSTON SCIENTIFIC CORP — Director's Dealing 2020

Jul 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-07-01

Reporting Person: Fitzgerald Joseph Michael (EVP & Pres, Interven Cardio)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-01	Stock Option (Right to Buy)	$35.2800	A	116959.0000	Acquired	2030-07-01	Common Stock (116959.0000)	Direct

Footnotes

F1: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in one installment on January 1, 2023.